Peptides

Semaglutide — The Most Extensively Studied Weight Loss Peptide Available Semaglutide  There are very few compounds in the history of metabolic medicine that have changed the conversation as completely as semaglutide. In clinical settings, the results it produces have surprised even the researchers running the trials. In the broader public, it has become one of…

Tirzepatide — The Dual Action Weight Loss Peptide That Outperformed Semaglutide Tirzepatide  For years, semaglutide held the position as the most effective pharmacological weight loss compound available. Then tirzepatide arrived — and the clinical trials changed the conversation again. In the first ever direct head-to-head comparison of the two compounds, published in the New England…

Research Peptides in the UK — The Honest Legal and Safety Guide Research Peptides in the UK There are two kinds of sites in this space when it comes to legal and safety information. Those that bury it in small print at the bottom of a page nobody reads. And those that put it front…

Tesofensine — The Accidental Weight Loss Compound That Outperformed Expectations Tesofensine Some of the most interesting discoveries in medicine happen by accident. Tesofensine was never designed to be a weight loss compound. It was developed by Danish pharmaceutical company NeuroSearch as a treatment for Parkinson’s disease and Alzheimer’s — a neurological drug targeting the brain’s…

5-Amino-1MQ — The NNMT Inhibitor That Targets the Enzyme Keeping Your Fat Cells in Storage Mode 5-Amino-1MQ There is an enzyme operating in your fat cells right now that most people have never heard of. It is called NNMT — nicotinamide N-methyltransferase — and in people with metabolic dysfunction, excess body fat or age-related metabolic…

AOD-9604 — The Precision Fat Loss Peptide That Targets Stubborn Adipose Tissue AOD-9604 Sometimes the most interesting compounds are not the ones that make the biggest headlines. While semaglutide and tirzepatide have dominated the weight loss conversation with their dramatic clinical trial numbers, AOD-9604 has quietly built a committed and loyal following in the research…

Retatrutide — The Triple Agonist That Is Rewriting the Rules of Weight Loss 28.7% average body weight reduction. In a Phase 3 clinical trial. Over 68 weeks. To put that number in context — most bariatric surgery procedures produce average weight loss of between 25% and 30%. The most effective pharmaceutical compound previously available —…